How strong is the link between GERD and pulmonary fibrosis?
The connection is substantial and has been confirmed by multiple types of studies. A large meta-analysis of 18 case-control studies, involving over 3,200 IPF patients and 9,300 controls, found that people with GERD were nearly three times more likely to have IPF (odds ratio of 2.94) [7]. This means the presence of GERD is associated with a roughly 3-fold higher chance of having IPF, though this doesn't prove GERD causes IPF.
A more recent genetic study using Mendelian randomization—a method that helps rule out reverse causation and confounding—found that GERD increases the risk of IPF by about 60% (odds ratio of 1.6) [1]. This is a more conservative estimate than the meta-analysis, but it's important because the genetic approach is better at isolating a true causal effect. The same study found no evidence that IPF causes GERD, suggesting the direction of the link is from reflux to lung disease, not the other way around [1].
However, not all studies agree. Another genetic analysis found that after adjusting for smoking, the link between GERD and IPF susceptibility was no longer statistically significant [2]. This highlights that smoking—a known risk factor for both conditions—may be a major confounder, meaning it could explain part of the apparent association.
Why might GERD lead to lung scarring?
The leading theory is that tiny amounts of stomach acid and other gastric contents are aspirated (inhaled) into the lungs over time, causing repeated microscopic injury that triggers scarring. This is supported by studies showing that IPF patients have abnormal acid exposure in the esophagus, especially at night and extending into the upper esophagus near the throat [5][6]. A 2014 study found that IPF patients with GERD had weaker upper esophageal sphincter pressure and slower acid clearance when lying down, both of which would increase the risk of aspiration [6].
Importantly, many IPF patients with GERD have no typical symptoms like heartburn—only about 25-47% report symptoms [4][5]. This "silent reflux" means the damage can occur without the person knowing, making it a hidden contributor. One study found that 16 out of 17 IPF patients had abnormal esophageal acid exposure on pH monitoring, but only 4 had typical reflux symptoms [5].
The link isn't limited to IPF. GERD also increases the risk of nontuberculous mycobacterial pulmonary disease (NTM-PD), another chronic lung condition, by more than 3-fold [3]. This suggests that aspiration of refluxed material may be a general mechanism that can contribute to various lung diseases, not just IPF.
Does treating GERD help with pulmonary fibrosis?
The evidence on treatment is mixed and inconclusive. Current guidelines have recommended antacid therapy for IPF patients, but a 2019 meta-analysis found that two recent meta-analyses of antacid therapy in IPF were inconclusive [7]. A review of the literature concluded that antiacid therapy was not able to change the evolution of IPF [4].
Some experts suggest that antireflux surgery might be more effective than medications, especially since the problem may involve not just acid but also other gastric contents and bile acids [4][6]. One study recommended that antireflux surgery should be considered early after diagnosis of both IPF and GERD, particularly because many patients have silent reflux and are at risk for aspiration [6]. However, large prospective studies are still needed to determine whether treating GERD—either with medication or surgery—actually improves outcomes for IPF patients [4].
The bottom line: while the link between GERD and IPF is well-established, it's not yet clear that treating GERD changes the course of the lung disease. Given the high prevalence of silent reflux in IPF, screening for GERD (even without symptoms) is reasonable, but patients should discuss the risks and benefits of treatment with their doctor.
About These Sources
This answer is built on 7 peer-reviewed studies — published from 1999 to 2023, 3 in Q1 journals, collectively cited 165 times — selected as the most relevant from 11 studies that passed quality screening, drawn from 47 papers retrieved from a database of over 500 million.
Sources used in this answer
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study
Using Mendelian randomization (a genetic method to infer causality), this study found that GERD increases the risk of IPF by about 60% (OR 1.6), but found no evidence that IPF causes GERD. This is the largest genetic analysis on this question.
Mendelian randomization analysis suggests no causal influence of gastroesophageal reflux disease on the susceptibility and prognosis of idiopathic pulmonary fibrosis
Another Mendelian randomization study found no causal effect of GERD on IPF susceptibility after adjusting for smoking, nor on IPF prognosis (lung function or survival), suggesting the link may be confounded by smoking.
Gastroesophageal Reflux Disease Increases Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease
In a large Korean cohort study, GERD was associated with a 3.36-fold increased risk of developing nontuberculous mycobacterial pulmonary disease (NTM-PD), another chronic lung condition, supporting the idea that reflux can contribute to lung disease.
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
A review found that GERD prevalence in IPF may be as high as 87%, but only about half of those patients report symptoms. The review concluded that antiacid therapy has not been shown to change IPF evolution.
Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.
A prospective study using esophageal pH monitoring found that 16 of 17 IPF patients had abnormal acid exposure, compared to 4 of 8 controls. Only 25% of IPF patients with abnormal reflux had typical symptoms.
Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.
A study comparing GERD patients with and without IPF found that IPF patients had weaker upper esophageal sphincter pressure, more proximal reflux, and slower acid clearance when lying down, all increasing aspiration risk.
Meta-analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis.
A meta-analysis of 18 case-control studies found that GERD is associated with IPF (OR 2.94), but after controlling for smoking in meta-regression, the association was no longer significant, suggesting confounding.